Request Free Sample
×
South Korea Asthma Inhaler Device Market
ID: MRFR/HC/54549-HCR
200 Pages
June 2025
South Korea Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035
Industry Developments
The South Korea Asthma Inhaler Device Market has seen significant developments recently, with a focus on the increasing prevalence of asthma, driving demand for advanced inhaler devices. Pfizer, AbbVie, GlaxoSmithKline, and Roche are some of the prominent players actively investing in innovation and product enhancements. In April 2023, Boehringer Ingelheim expanded its portfolio with a new inhaler technology aimed at improving patient adherence. UCB has also been advancing its research in digital inhaler systems. January 2023 marked the launch of a collaborative effort by Novartis and Sanofi to enhance patient access to asthma treatments. Additionally, AstraZeneca's marketing strategies focused on increasing awareness of inhaler usage significantly contributed to market growth. Over the past couple of years, the South Korean government has prioritized asthma management, evidenced by new healthcare policies introduced in June 2022 that support improved access to inhalers and better patient education. The market valuation for inhaler devices is expected to rise as the country adapts to new healthcare standards and technology, with companies like Mylan and Teva Pharmaceuticals also exploring opportunities for growth in this competitive landscape through potential partnerships and product launches.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 30.8(USD Million) |
| MARKET SIZE 2024 | 33.88(USD Million) |
| MARKET SIZE 2035 | 75.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.492% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, AbbVie, GlaxoSmithKline, Roche, Boehringer Ingelheim, UCB, Mylan, Novartis, Chiesi Pharmaceutical, Sanofi, Reckitt Benckiser, AstraZeneca, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Merck & Co |
| SEGMENTS COVERED | Type, Mode of Operation, End User |
| KEY MARKET OPPORTUNITIES | Growing asthma prevalence rates, Advancements in smart inhaler technology, Increasing demand for personalized medicine, Rising awareness of respiratory health, Expansion of telemedicine and digital solutions |
| KEY MARKET DYNAMICS | growing asthma prevalence, advanced inhaler technology, increasing healthcare expenditure, rising awareness and education, government support and initiatives |
| COUNTRIES COVERED | South Korea |
FAQs
What is the expected market size of the South Korea Asthma Inhaler Device Market in 2024?
The South Korea Asthma Inhaler Device Market is expected to be valued at 33.88 million USD in 2024.
What is the projected market size for the South Korea Asthma Inhaler Device Market in 2035?
By 2035, the South Korea Asthma Inhaler Device Market is projected to grow to 75.0 million USD.
What is the compound annual growth rate (CAGR) for the South Korea Asthma Inhaler Device Market from 2025 to 2035?
The CAGR for the South Korea Asthma Inhaler Device Market is expected to be 7.492% from 2025 to 2035.
Which segment of the South Korea Asthma Inhaler Device Market is anticipated to hold the largest market share in 2024?
In 2024, Metered Dose Inhalers are expected to dominate with a market value of 14.5 million USD.
What is the market value projection for the Dry Powder Inhalers segment by 2035?
The Dry Powder Inhalers segment is projected to reach a market value of 22.0 million USD by 2035.
What are some emerging trends in the South Korea Asthma Inhaler Device Market?
Emerging trends include advancements in inhaler technology and increased focus on patient adherence and convenience.
Who are the key players in the South Korea Asthma Inhaler Device Market?
Major players in the market include Pfizer, AbbVie, GlaxoSmithKline, and Roche, among others.
What is the expected market value of the Soft Mist Inhalers segment in 2024?
The Soft Mist Inhalers segment is expected to be valued at 9.38 million USD in 2024.
How is the growth rate for the South Korea Asthma Inhaler Device Market expected to impact various segments?
The overall growth rate is likely to boost all segments, with significant expansion in both Metered Dose and Dry Powder Inhalers.
What challenges does the South Korea Asthma Inhaler Device Market currently face?
Challenges include strict regulatory requirements and the need for continuous innovation to meet patient needs.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment